Volume 67, Issue 5 p. e99
PLAIN LANGUAGE SUMMARY
Free Access

Pathogenic variants in chromatin-related genes: Linking immune dysregulation to neuroregression and acute neuropsychiatric disorders

First published: 13 March 2025

Even though every cell in the body has the same DNA, different genes are turned on or off depending on the cell type. This allows cells to perform specialized jobs, like helping the brain process information, or the immune system fight infections. These changes in gene activity are controlled by a process called epigenetics, which acts like a switch to regulate gene function without altering the DNA itself. One key part of this process involves chromatin, a structure that helps organize DNA. Changes in genes related to chromatin can affect how cells function and may lead to complex health conditions that impact multiple organs.

We report on eight children who had genetic DNA changes in these chromatin-related genes. All of these children experienced a sudden worsening – a ‘regression’ of their neurodevelopmental condition after an infection or other immune triggers. Some lost social and language skills, while others developed new psychiatric symptoms like obsessive-compulsive disorder, tics, or severe anxiety. We also found that several children had a history of immune system problems, such as frequent infections or autoimmune conditions. One key finding was that these chromatin-related genes are active not only in brain cells but also in immune cells. This suggests that changes in these genes may make the immune system react differently to infections, which could then impact brain function.

This study does not suggest that infections cause neurodevelopmental conditions. Instead, it highlights how rare genetic factors might make some children more vulnerable to environmental influences, such as infections. Some children in the study benefited from immune-targeted treatments like intravenous immunoglobulin (IVIG) or antibiotics. While more research is needed, this suggests that immune-based therapies might help certain children. These findings support the idea that the immune system and brain development are closely connected. Future research could lead to more personalized treatments for children experiencing neurodevelopmental regression.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.